BTIG Reiterates Buy on Edwards Lifesciences, Maintains $110 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 83.3%

Neg 0% Neu 83.3% Pos 0%

BTIG analyst Marie Thibault reiterates Edwards Lifesciences (NYSE:EW) with a Buy and maintains $110 price target.

Comments

No comments yet. Be the first!